MedPath

OPTIMIZATION of ADVANCED MR SEQUENCES

Recruiting
Conditions
MRI
Mental Disorders
Brain Tumor
Neurosciences
Stroke
Registration Number
NCT05618990
Lead Sponsor
Centre Hospitalier St Anne
Brief Summary

This monocentric methodological study aims at optimizing advanced MR sequences for image quality (reduced artefacts, signal to noise ratio, acquisition time, stability of quantitative measurements) on a new MR unit dedicated to research in clinical and cognitive neuroscience.

Detailed Description

Primary goal : Optimization of MR protocols and validation of acquisition parameters of advanced MR sequences on healthy volunteers or patients on a new 3T MR unit dedicated to research in neurosciences.

Secondary goals

1. Perform acquisitions to validate the feasibility of research MR protocols (pilot subjects)

2. reproducibility studies

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
300
Inclusion Criteria
  • 18 ans
  • Covered by social security
  • For women in age of procreation, under efficient contraception
  • Written consent
Exclusion Criteria
  • Any MR contraindication
  • Claustrophobia
  • Pregnancy
  • Under judiciary protection

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
MR sequences optimization72 months

Optimization of MR protocols and validation of acquisition parameters of advanced MR sequences on healthy volunteers or patients on a new 3T MR unit dedicated to research in neurosciences. Outcome measures depend on each pulse optimized sequence (signal-to-noise ratio, contrast-to-noise ratio, quantitative MR biomarkers).

Secondary Outcome Measures
NameTimeMethod
Reproducibility studies72 months

Reproducibility studies (quantitative parameters, effect of denoising ...). Outcome measures depend on each pulse optimized sequence (artifacts, signal-to-noise ratio, contrast-to-noise ratio, quantitative MR biomarkers).

Pilot studies72 months

Feasibility studies in cognitive neurosciences. Outcome measures depend on each MR protocol (artifacts, signal-to-noise ratio, contrast-to-noise ratio, quantitative MR biomarkers).

Trial Locations

Locations (1)

OPPENHEIM Catherine

🇫🇷

Paris, France

© Copyright 2025. All Rights Reserved by MedPath